Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion type Assertion NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_head.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion evidence source_evidence_literature NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion SIO_000772 16488990 NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion wasDerivedFrom befree-2016 NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion wasGeneratedBy ECO_0000203 NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.